Angle announced on Friday the successful completion of assay development projects for AstraZeneca and Eisai, further ...
One of the key challenges of the modern genomics era is studying the thousands of genes in a single human cell at scale. To ...
For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...
As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...
ON ASTRAZENECA ASSAY DEVELOPMENT PROJECTS AND SUCCESSFUL COMPLETION OF EISAI CONTRACT Development of both the prostate cancer ...
Adaptive Biotechnologies (ADPT) has launched an upgraded version of its clonoSEQ assay for measurable residual disease detection in diffuse ...
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ ...
Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.
The following is a summary of “Diagnostic-avoiding Chlamydia trachomatis variants detected in cervical and endometrial ...
Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback